SHELBY BRUENING: Open Payments
NPI 1881284966 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 55 payments from 14 companies in 2025. Trend: 2023 $2,813 · 2024 $782 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $368 |
| Globus Medical, Inc. | 3 | $204 |
| PFIZER INC. | 8 | $163 |
| Collegium Pharmaceutical, Inc. | 10 | $137 |
| Lundbeck LLC | 3 | $71 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $64 |
| SPR Therapeutics, Inc | 2 | $58 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| MML US, Inc. | 2 | $33 |
Products named: Senza, UBRELVY, NURTEC ODT, Belbuca, QULIPTA, BOTOX, VYEPTI, SPRINT PNS System.
Industry payments across NE — which companies pay providers there.
